Top Competitors of BSX in the Endoscopy Space Stryker ’s SYK Endoscopy segment posted strong growth in the first quarter, with U.S. organic sales rising 11.1%, driven by double-digit gains in ...

Boston Scientific Corporation (BSX)’s share was trading at $94.27 as of April 14th. BSX’s trailing and forward P/E were 75.42 and 33.11 respectively according to Yahoo Finance.

Shares of BSX have also skyrocketed nearly 53.7% over the past 52 weeks, significantly outperforming XLV’s 1.4% gains over the same time frame.

Boston Scientific’s revenue climbed 32%, rising from $12.7 billion in 2022 to $16.7 billion in 2024, driven by an increase in total procedures and the introduction of new products such as POLARx ...

We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands ...

PAHC currently has a forward P/E ratio of 13.32, while BSX has a forward P/E of 35.50. We also note that PAHC has a PEG ratio of 0.51. This metric is used similarly to the famous P/E ratio, but ...

Boston Scientific’s BSX +1.9% performance was also in line with its peers, including Medtronic MDT +0.6%, Abbott, and Intuitive Surgical ISRG -0.1%, all down between 8% and 12% over the last month.

The BSX hosted its bell-ringing ceremony at 9am as part of the annual Women’s Day event hosted by the Bermuda International Women’s Day Committee in partnership with the Women’s Resource Centre.

Top Competitors of BSX in the Endoscopy Space Stryker ’s SYK Endoscopy segment posted strong growth in the first quarter, with U.S. organic sales rising 11.1%, driven by double-digit gains in ...